Overview
Obligated since award on contracts active FY2021–FY2026
Click a company to open its profile.
Insight NATIONAL INSTITUTES OF HEALTH NIDA (75N950) is its largest buyer. See more on the Buyers tab
Agencies report with a delay; the latest year will rise
Hover over a year to see its value.
Insight Largest year: $1.84M in FY2021. See more on the Contracts tab
Click a state to open its page.
- North Carolina$2.67M · 100%
Insight 100% was performed in North Carolina. See more on the Contracts tab
Contracts
2 contracts with an action since FY2021
Click a bar to open its contract.
Insight Stand-alone contracts hold 100% of these contracts' obligations.
Avista Pharma Solutions, Inc. prime contracts with an action in FY2021–FY2026
Find a contract by vehicle, office or end date; sort by money to see the largest.
0 end within 12 months.
Showing 1–2 of 2 contracts
| Since award, US$ | |||||
|---|---|---|---|---|---|
| Parent contract (IDVIDV: the record type for any contract that exists to take orders: IDIQs, GWACs, GSA Schedules, BPAs and basic ordering agreements. Glossary) | ObligatedObligation: money the government has legally committed to a contract. It is not the same as money paid. Example: $6M obligated of a $10M ceiling. Glossary | ||||
| 75N95021P00063 | Stand-alone | NATIONAL INSTITUTES OF HEALTH NIDA (75N950) | $2,086,294 | Dec 31, 2024 | Ended |
| 75N95022P00137 | Stand-alone | NATIONAL INSTITUTES OF HEALTH NIDA (75N950) | $581,604 | Oct 31, 2022 | Ended |
Buyers
National Institutes of Health: $2.67M obligated since award; $2.67M in FY2021–FY2025 actions
Click a bar to open its office page.
Insight National Institutes of Health placed 100%.
Contracting offices that awarded Avista Pharma Solutions prime contracts, FY2021–FY2026
See which offices award its contracts.
0 offices awarded only one contract.
Showing 1–1 of 1 office
| Contracts active FY2021–FY2026; obligated since award, US$ | |||||
|---|---|---|---|---|---|
| NATIONAL INSTITUTES OF HEALTH NIDA (75N950) | National Institutes of Health | 2 | $2,667,898 | Dec 31, 2020 | May 13, 2026 |
Teaming
Subcontracts Avista Pharma Solutions, Inc. received, by prime order
Whom it works under and on what.
1 order, all under 75N92022A00005.
Showing 1–1 of 1 subcontract
| Research Triangle Institute | 75N92024F00001under 75N92022A00005 | NATIONAL INSTITUTES OF HEALTH NHLBI (75N920) | $217,879 | Oct 30, 2024 |
Opportunities
Open opportunities matching Avista Pharma Solutions, Inc.'s registered industries
Notices in its 1 industry (NAICSNAICS code: a six-digit code for the kind of work a company does. Each contract carries one, and it sets the small-business size limit. Glossary): 325411
No open notice matches these industries today. New notices arrive every day.
Registration and contacts
Registration
- UEI
- GRKKCA8LJNE4
- CAGE code
- 1YBV9
- Registration
- Active, expires Dec 10, 2026
- Entity type
- Corporate Entity (Not Tax Exempt)
- Location
- DURHAM, NC, 27713
- Congressional district
- NC-04
Registered industries (NAICSNAICS code: a six-digit code for the kind of work a company does. Each contract carries one, and it sets the small-business size limit. Glossary)
Registered in 1 industry; primary 325411
- 325411 Medicinal and Botanical ManufacturingPrimary
Contacts at Avista Pharma Solutions, Inc.
| Contact | Role | As of |
|---|---|---|
| No public contact on file | ||
Correct this listing
Tell us what to correct or add on the Avista Pharma Solutions, Inc. page. We check every request before we change a profile.